Pathophysiology and inflammatory biomarkers of sulfur mustard-induced corneal injury in rabbits

Sulfur mustard (SM) is a cytotoxic, vesicating, chemical warfare agent, first used in 1917; corneas are particularly vulnerable to SM exposure. They may develop inflammation, ulceration, neovascularization (NV), impaired vision, and partial/complete blindness depending upon the concentration of SM, exposure duration, and bio-physiological conditions of the eyes. Comprehensive in vivo studies have established ocular structural alterations, opacity, NV, and inflammation upon short durations (<4 min) of SM exposure. In this study, detailed analyses of histopathological alterations in corneal structure, keratocytes, inflammatory cells, blood vessels, and expressions of cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-9, vascular endothelial growth factor (VEGF), and cytokines were performed in New Zealand white rabbits, in a time-dependent manner till 28 days, post longer durations (5 and 7 min) of ocular SM exposure to establish quantifiable endpoints of injury and healing. Results indicated that SM exposure led to duration-dependent increases in corneal thickness, opacity, ulceration, epithelial-stromal separation, and epithelial degradation. Significant increases in NV, keratocyte death, blood vessels, and inflammatory markers (COX-2, MMP-9, VEGF, and interleukin-8) were also observed for both exposure durations compared to the controls. Collectively, these findings would benefit in temporal delineation of mechanisms underlying SM-induced corneal toxicity and provide models for testing therapeutic interventions.

[1]  Celinia A. Ondeck,et al.  Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyes. , 2021, Toxicology letters.

[2]  T. Kadar,et al.  Therapeutic measures for sulfur mustard-induced ocular injury. , 2021, Toxicology letters.

[3]  L. Kenar,et al.  Evidence of sulfur mustard exposure in victims of chemical terrorism by detection of urinary β-lyase metabolites , 2020, Clinical toxicology.

[4]  R. Enzenauer,et al.  Acute corneal injury in rabbits following nitrogen mustard ocular exposure. , 2019, Experimental and molecular pathology.

[5]  A. Moghadamnia,et al.  Therapeutic options to treat mustard gas poisoning – Review , 2019, Caspian journal of internal medicine.

[6]  F. Worek,et al.  Forensic evidence of sulfur mustard exposure in real cases of human poisoning by detection of diverse albumin-derived protein adducts , 2019, Archives of Toxicology.

[7]  A. Zvi,et al.  A comprehensive analysis of corneal mRNA levels during sulfur mustard induced ocular late pathology in the rabbit model using RNA sequencing. , 2019, Experimental eye research.

[8]  T. Kadar,et al.  Differential expression of corneal and limbal cytokines and chemokines throughout the clinical course of sulfur mustard induced ocular injury in the rabbit model , 2018, Experimental eye research.

[9]  Y. Panahi,et al.  A review on symptoms, treatments protocols, and proteomic profile in sulfur mustard‐exposed victims , 2018, Journal of cellular biochemistry.

[10]  R. Agarwal,et al.  Efficacy of anti-inflammatory, antibiotic and pleiotropic agents in reversing nitrogen mustard-induced injury in ex vivo cultured rabbit cornea. , 2017, Toxicology letters.

[11]  S. Feizi,et al.  Therapeutic approaches for corneal neovascularization , 2017, Eye and Vision.

[12]  R. Enzenauer,et al.  Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Y. Panahi,et al.  Ocular Effects of Sulfur Mustard and Therapeutic Approaches , 2017, Journal of cellular biochemistry.

[14]  K. Svoboda,et al.  The molecules in the corneal basement membrane zone affected by mustard exposure suggest potential therapies , 2016, Annals of the New York Academy of Sciences.

[15]  R. Agarwal,et al.  Corneal toxicity induced by vesicating agents and effective treatment options , 2016, Annals of the New York Academy of Sciences.

[16]  P. McNutt,et al.  Contributions of tissue‐specific pathologies to corneal injuries following exposure to SM vapor , 2016, Annals of the New York Academy of Sciences.

[17]  R. Enzenauer,et al.  Clinical progression of ocular injury following arsenical vesicant lewisite exposure , 2016, Cutaneous and ocular toxicology.

[18]  R. Enzenauer,et al.  Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization , 2016, Cornea.

[19]  T. Kadar,et al.  The Beneficial Effects of Doxycycline, An Inhibitor of Matrix Metalloproteinases, on Sulfur Mustard-Induced Ocular Pathologies Depend on the Injury Stage , 2014, Current eye research.

[20]  T. Kadar,et al.  Anti-VEGF Therapy (Bevacizumab) for Sulfur Mustard-Induced Corneal Neovascularization Associated with Delayed Limbal Stem Cell Deficiency in Rabbits , 2014, Current eye research.

[21]  B. Najafian,et al.  Serum Matrix Metalloproteinase Levels in Patients Exposed to Sulfur Mustard , 2014, Iranian Red Crescent medical journal.

[22]  V. Romano,et al.  Corneal oedema and its medical treatment , 2013, Clinical & experimental optometry.

[23]  S. Faghihzadeh,et al.  A clinicopathological approach to sulfur mustard-induced organ complications: a major review , 2013, Cutaneous and ocular toxicology.

[24]  David J Hilber,et al.  Development of a mouse model for sulfur mustard-induced ocular injury and long-term clinical analysis of injury progression , 2013, Cutaneous and ocular toxicology.

[25]  Lilian Gonzalez,et al.  Nanotechnology in corneal neovascularization therapy--a review. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[26]  R. Enzenauer,et al.  Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries. , 2012, Toxicology and applied pharmacology.

[27]  P. McNutt,et al.  Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms , 2012, PloS one.

[28]  P. McNutt,et al.  Pathogenesis of Acute and Delayed Corneal Lesions After Ocular Exposure to Sulfur Mustard Vapor , 2012, Cornea.

[29]  S. Tseng,et al.  Sulfur mustard-induced ocular surface disorders. , 2011, The ocular surface.

[30]  M. Tansey,et al.  The Role of Neuroinflammation in Parkinson's Disease , 2011 .

[31]  M. Gallo,et al.  Doxycycline hydrogels as a potential therapy for ocular vesicant injury. , 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[32]  G. C. Rodgers,et al.  Antidotes and Treatments for Chemical Warfare/Terrorism Agents: An Evidence‐Based Review , 2010, Clinical pharmacology and therapeutics.

[33]  P. McNutt,et al.  Progression of ocular sulfur mustard injury: development of a model system , 2010, Annals of the New York Academy of Sciences.

[34]  D. Laskin,et al.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  P. Sinko,et al.  Doxycycline loaded poly(ethylene glycol) hydrogels for healing vesicant-induced ocular wounds. , 2010, Biomaterials.

[36]  K. Kehe,et al.  Acute effects of sulfur mustard injury--Munich experiences. , 2009, Toxicology.

[37]  A. Solomon,et al.  Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy. , 2009, Toxicology.

[38]  M. Naderi,et al.  Prophylactic ophthalmic bethametazone for sulfur mustard-induced ocular injury , 2009, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[39]  De-Quan Li,et al.  Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. , 2009, Investigative ophthalmology & visual science.

[40]  K. Meek,et al.  Corneal collagen—its role in maintaining corneal shape and transparency , 2009, Biophysical Reviews.

[41]  Philip Bao,et al.  The role of vascular endothelial growth factor in wound healing. , 2009, The Journal of surgical research.

[42]  S. Faghihzadeh,et al.  Systemic and ocular complications of sulfur mustard: A panoramic review , 2009 .

[43]  R. Enzenauer,et al.  Ocular Toxicity of Sulfur Mustard , 2009 .

[44]  M. Balali-Mood,et al.  Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans , 2008, Emerging health threats journal.

[45]  M. Balali-Mood,et al.  Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. , 2006, Basic & clinical pharmacology & toxicology.

[46]  T. Rudge,et al.  Preferential expression of matrix metalloproteinase‐9 in mouse skin after sulfur mustard exposure , 2006, Journal of applied toxicology : JAT.

[47]  J. West-Mays,et al.  The keratocyte: corneal stromal cell with variable repair phenotypes. , 2006, The international journal of biochemistry & cell biology.

[48]  K. Kehe,et al.  Medical aspects of sulphur mustard poisoning. , 2005, Toxicology.

[49]  M. Mahmoudi,et al.  Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. , 2005, International immunopharmacology.

[50]  M. Balali-Mood,et al.  The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning , 2005, Fundamental & clinical pharmacology.

[51]  E. Berenshtein,et al.  Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids. , 2005, Investigative ophthalmology & visual science.

[52]  S. Yazdani,et al.  Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. , 2005, Ophthalmology.

[53]  M. Balali-Mood,et al.  THE CLINICAL TOXICOLOGY OF SULFUR MUSTARD , 2005 .

[54]  E. Berenshtein,et al.  Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard. , 2003, Investigative ophthalmology & visual science.

[55]  T. Kadar,et al.  Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits , 2001, Current eye research.

[56]  M. Safarinejad,et al.  Ocular injuries caused by mustard gas: diagnosis, treatment, and medical defense. , 2001, Military medicine.

[57]  E. Gilat,et al.  Beneficial effects of topical anti‐inflammatory drugs against sulfur mustard‐induced ocular lesions in rabbits , 2000, Journal of applied toxicology : JAT.

[58]  N. Šimac The Black Book of Communism , 1998 .

[59]  E. J. Hogendoorn A Chemical Weapons Atlas , 1997 .

[60]  David R Franz,et al.  Medical Aspects of Chemical and Biological Warfare , 1997 .

[61]  J. Dacre,et al.  Toxicology and pharmacology of the chemical warfare agent sulfur mustard. , 1995, Pharmacological reviews.

[62]  C. Cubitt,et al.  Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. , 1995, Investigative ophthalmology & visual science.

[63]  C. Cubitt,et al.  IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. , 1993, Investigative ophthalmology & visual science.

[64]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[65]  M. Fini,et al.  COLLAGENOLYTIC/GELATINOLYTIC ENZYMES IN CORNEAL WOUND HEALING , 1992, Acta ophthalmologica. Supplement.

[66]  J. Foidart,et al.  Collagens and non collagenous proteins in the human eye. I. Corneal stroma in vivo and keratocyte production in vitro. , 1981, Current eye research.

[67]  W. Geeraets,et al.  Acute corneal injury by mustard gas. , 1977, Southern medical journal.